Keyphrases
Area Cover
25%
Cancer Predisposition Syndrome
25%
Collaborative Care
25%
Current Treatment
25%
Diagnostic Work-up
25%
Difficult-to-treat
25%
Expert Opinion
25%
High Mortality Rate
25%
Highly Aggressive
25%
Investigational Treatments
25%
Malignancy
50%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
100%
Molecular Etiology
25%
Neurofibromatosis Type 1 (NF-1)
100%
Neurofibromatosis Type I
100%
Patient Response
25%
Plexiform Neurofibroma
25%
Sarcoma
25%
Sarcoma Center
25%
Targeted Combinational Therapy
25%
Therapeutic Challenges
25%
Therapeutic Potential
25%
Treatment Options
25%
Tumor
75%
Tumor Challenge
100%
Tumor Development
25%
Tumor Progression
25%
Medicine and Dentistry
Cancer
66%
Cancer Susceptibility
33%
Connective Tissue Cancer
66%
Diagnosis
33%
Experimental Therapy
33%
Malignant Neoplasm
33%
Malignant Peripheral Nerve Sheath Tumor
100%
Molecular Pathology
33%
Mortality Rate
33%
Neoplasm
100%
Neurofibromatosis Type I
100%
Plexiform Neurofibroma
33%
Pharmacology, Toxicology and Pharmaceutical Science
Cancer Susceptibility
33%
Connective Tissue Cancer
66%
Malignant Neoplasm
33%
Malignant Peripheral Nerve Sheath Tumor
100%
Molecular Pathology
33%
Mortality Rate
33%
Neoplasm
100%
Neurofibroma
33%
Neurofibromatosis Type 1
100%
Syndrome
33%